Jonathan Wosen
Biotech and Life Sciences Reporter at STAT
West Coast Biotech & Life Sciences Reporter for @statnews. Formerly with @sdut. @Stanford Immunology PhD & @UCSC_SciCom alum. Tips? [email protected]
Articles
-
2 weeks ago |
statnews.com | Jonathan Wosen
Facing billions of dollars in proposed cuts to research overhead payments from the Trump administration, a coalition of academic groups has devised plans it believes could be more sensible, measured ways to revamp how the federal government pays for scientific research. STAT obtained a copy of the proposals, which were developed by the Joint Associations Group, or JAG, a collection of 10 organizations that represent universities, medical centers, and other research institutions.
-
2 weeks ago |
statnews.com | Jonathan Wosen
National Institutes of Health Director Jay Bhattacharya faced sharp questions on Tuesday from Republican and Democratic members of a Senate appropriations subcommittee about the agency’s 2026 budget, with lawmakers struggling to reconcile his stated commitment to biomedical research with recent grant terminations, funding delays, and the Trump administration’s sweeping proposed spending cuts. In a particularly tense moment, Sen.
-
3 weeks ago |
statnews.com | Jonathan Wosen |Daniel Payne
WASHINGTON — President Trump’s 2026 budget proposes slashing the National Institutes of Health’s central function, supporting research by awarding grants to universities, academic medical centers, and other institutions, by 43% compared to 2025 levels. New documents released by the agency show an $11.6 billion cut in this funding, to $15.1 billion, which would both reduce the number of new grants awarded as well as existing grants for ongoing research.
-
3 weeks ago |
statnews.com | Jonathan Wosen
Kymera Therapeutics on Monday reported that an experimental drug designed to rival Sanofi and Regeneron’s blockbuster therapy Dupixent succeeded in a closely watched early-stage trial. The Phase 1 trial, which enrolled 118 healthy volunteers, tested the safety and tolerability of KT-621, a small molecule drug that targets STAT6, a signaling protein that plays a key role in driving immune activation.
-
4 weeks ago |
statnews.com | Jonathan Wosen |Daniel Payne
The Department of Health and Human Services on Friday released a summary of President Donald Trump’s budget request for the 2026 fiscal year that provides the most detailed look yet at how his administration hopes to reshape the National Institutes of Health and other federal agencies. The “budget in brief” document doubles down on a previous request to slash NIH’s discretionary budget to $27.5 billion, an $18 billion or nearly 40% reduction.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 3K
- Tweets
- 3K
- DMs Open
- Yes
In the fight over research overhead funding, universities propose alternatives to Trump’s cuts. A @statnews exclusive by me. For more details, see our story. https://t.co/DlukVYPzCo
Just hours after RFK Jr. announced a new CDC vaccine advisory panel, 7 (!!) of my @statnews colleagues put together this staggeringly thorough breakdown of what we know about the new ACIP members. Well worth a read. 👇 https://t.co/tnoVRUAtQX
"The medical and scientific community will no longer trust the advice that comes out of the ACIP, and will look to form their own committees,” @DrPaulOffit told @statnews after RFK Jr. announced the new vaccine advisory panel. https://t.co/vq4glPVpRE